Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- N/A
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
- Status
- SUSPENDED
- Phase
- PHASE1
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
- Status
- RECRUITING
- Phase
- N/A
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
- Status
- RECRUITING
- Phase
- PHASE2
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
- Status
- RECRUITING
- Phase
- PHASE2
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial
- Status
- SUSPENDED
- Phase
- PHASE1
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
- Status
- RECRUITING
- Phase
- PHASE2
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
- Status
- RECRUITING
- Phase
- PHASE2
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1